我是 LongbridgeAI，我可以總結文章信息。Kahn Swick & Foti, LLC 正在調查 Forte Biosciences (FBRX) 擬議出售給 argenx SE 的交易。該交易為股東提供每股 77.00 美元的現金。該律師事務所正在評估這個價格和交易過程是否合理，或者是否低估了公司的價值。對潛在低估感到擔憂或希望討論法律權利的股東被鼓勵聯繫管理合夥人 Lewis S. Kahn
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Forte Biosciences, Inc. (NasdaqCM: FBRX) to argenx SE (NasdaqGS: ARGX). Under the terms of the proposed transaction, shareholders of Forte will receive $77.00 in cash for each share of Forte that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at (833) 538-3612, or visit https://www.ksfcounsel.com/cases/nasdaqcm-fbrx/ to learn more.
Please note that the transaction is structured as a tender offer, such that time may be of the essence.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn
Kahn Swick & Foti, LLC
Lewis S. Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
(833) 538-3612
1100 Poydras St., Suite 960
New Orleans, LA 70163
View source version on businesswire.com: https://www.businesswire.com/news/home/20260811200449/en/